International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Codeine Phosphate 3 mg/mL in Ora-Sweet

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2022 - Volume 26, Number 2
View All Articles in Issue

Page(s): 141

Codeine Phosphate 3 mg/mL in Ora-Sweet Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Codeine Phosphate 3 mg/mL in Ora-Sweet. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, codeine phosphate, pain relief, pain control, oral suspension, analgesic, analgesia

Related Categories: EXCIPIENTS, FORMULATIONS, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Codeine Phosphate 3 mg/mL in Ora-Sweet Allen Loyd V Jr	Mar/Apr 2022 Pg. 141
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Allen Loyd V Jr	Nov/Dec 2015 Pg. 504
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 502
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 236
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2003 Pg. 304
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen Zugerman Jessie Jean M, Reed Thomas C	Nov/Dec 2007 Pg. 514-519
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension Allen Loyd V Jr	Jul/Aug 2019 Pg. 314
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 509
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules Allen Loyd V Jr	Sep/Oct 2005 Pg. 386
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules Allen Loyd V Jr	Sep/Oct 2005 Pg. 387
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules Allen Loyd V Jr	Sep/Oct 2005 Pg. 388
Return to Top